137 related articles for article (PubMed ID: 6086025)
1. Platelet enzyme activities in diabetes mellitus in relation to endothelial damage.
Janka HU; Standl E; Schramm W; Mehnert H
Diabetes; 1983 May; 32 Suppl 2():47-51. PubMed ID: 6086025
[TBL] [Abstract][Full Text] [Related]
2. Increased platelet adenylate cyclase activity ion diabetic patients with microangiography.
Janka HU; Standl E; Mehnert H
Horm Metab Res Suppl; 1981; 11():26-9. PubMed ID: 6172351
[TBL] [Abstract][Full Text] [Related]
3. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications.
Gisinger C; Schernthaner G
Diabetes Res; 1986 Oct; 3(8):401-5. PubMed ID: 3545622
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of beta-thromboglobulin and factor VIII-related antigen in diabetic children and adults.
Rak K; Beck P; Udvardy M; Pfliegler G; Misz M; Boda Z
Thromb Res; 1983 Jan; 29(2):155-62. PubMed ID: 6189237
[TBL] [Abstract][Full Text] [Related]
5. Do platelets have anything to do with diabetic microvascular disease?
Colwell JA; Winocour PD; Halushka PV
Diabetes; 1983 May; 32 Suppl 2():14-9. PubMed ID: 6242836
[TBL] [Abstract][Full Text] [Related]
6. Platelet sensitivity to prostacyclin in diabetes mellitus.
Pillay PK; Pillay U; Balasubramaniam P; Lee KO
Ann Acad Med Singap; 1985 Apr; 14(2):229-31. PubMed ID: 3898978
[TBL] [Abstract][Full Text] [Related]
7. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
Chen SY; Yu BJ; Liang YQ; Lin WD
Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
[TBL] [Abstract][Full Text] [Related]
8. Platelets and diabetic vascular disease.
Paton RC; Passa P
Diabete Metab; 1983 Dec; 9(4):306-12. PubMed ID: 6230270
[TBL] [Abstract][Full Text] [Related]
9. Platelet aggregation and plasma levels of beta-thromboglobulin in diabetes mellitus.
Yamada K; Mori K; Goto Y
Tohoku J Exp Med; 1981 Dec; 135(4):423-9. PubMed ID: 6175049
[TBL] [Abstract][Full Text] [Related]
10. A study of platelet-relevant parameters in patients with diabetic microangiopathy.
Porta M; Peters AM; Cousins SA; Cagliero E; FitzPatrick ML; Kohner EM
Diabetologia; 1983 Jul; 25(1):21-5. PubMed ID: 6224713
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
12. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
[TBL] [Abstract][Full Text] [Related]
13. Human prostacyclin platelet receptors in diabetes mellitus.
Modesti PA; Fortini A; Gensini GF; Vanni D; Prisco D; Abbate R
Thromb Res; 1991 Sep; 63(5):541-8. PubMed ID: 1755006
[TBL] [Abstract][Full Text] [Related]
14. Decreased platelet phosphoinositide turnover and enhanced platelet activation in IDDM.
Bastyr EJ; Kadrofske MM; Dershimer RC; Vinik AI
Diabetes; 1989 Sep; 38(9):1097-102. PubMed ID: 2548908
[TBL] [Abstract][Full Text] [Related]
15. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
[TBL] [Abstract][Full Text] [Related]
16. Platelets from diabetic subjects show diminished sensitivity to prostacyclin.
Betteridge DJ; El Tahir KE; Reckless JP; Williams KI
Eur J Clin Invest; 1982 Oct; 12(5):395-8. PubMed ID: 6816610
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet adenylate cyclase by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor).
Haslam RJ; Vanderwel M
J Biol Chem; 1982 Jun; 257(12):6879-85. PubMed ID: 6177688
[No Abstract] [Full Text] [Related]
18. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
[TBL] [Abstract][Full Text] [Related]
19. Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects.
Shepherd GL; Lewis PJ; Blair IA; de Mey C; MacDermot J
Br J Clin Pharmacol; 1983 Jan; 15(1):77-81. PubMed ID: 6342639
[TBL] [Abstract][Full Text] [Related]
20. Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy.
Preston FE; Ward JD; Marcola BH; Porter NR; Timperley WR; O'Malley BC
Lancet; 1978 Feb; 1(8058):238-40. PubMed ID: 74664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
